Publication: Evidence-based decision making in healthcare in Central Eastern Europe
| dc.contributor.author | Ferrario, Alessandra (55621505500) | |
| dc.contributor.author | Baltezarević, Dragana (55640347300) | |
| dc.contributor.author | Novakovic, Tanja (55371434000) | |
| dc.contributor.author | Parker, Mark (57201753849) | |
| dc.contributor.author | Samardzic, Janko (23987984500) | |
| dc.date.accessioned | 2025-06-12T20:08:51Z | |
| dc.date.available | 2025-06-12T20:08:51Z | |
| dc.date.issued | 2014 | |
| dc.description.abstract | The Pharmacoeconomics Section of the Pharmaceutical Association of Serbia organized a 2-day international conference on decision making in healthcare in Central and Eastern Europe with a focus on reimbursement decisions for medicines using health technology assessment (HTA) [1]. The aim of this conference was to showcase best practice examples in pricing and reimbursement decision making in Europe and also discuss common challenges and possible ways to overcome them, present new pharmacoeconomic methodologies and outcomes research techniques and learn about the latest trends in health economics modeling. Speakers included international and local experts in pricing and reimbursement decisions representing different stakeholder groups. | |
| dc.identifier.uri | https://doi.org/10.1586/14737167.2014.946014 | |
| dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84907047435&doi=10.1586%2f14737167.2014.946014&partnerID=40&md5=df5c9efa7dee6057238534b6874bf16b | |
| dc.identifier.uri | https://remedy.med.bg.ac.rs/handle/123456789/8559 | |
| dc.title | Evidence-based decision making in healthcare in Central Eastern Europe | |
| dspace.entity.type | Publication |